Fundraising Fox
/Companies
Sign in

Cardurion Pharmaceuticals, Inc.

Burlington, US · Founded 2017 · Delaware corporation · 6 known investors

Find your way into Cardurion Pharmaceuticals, Inc.

Biotech

Founders & leadership

MM
Michael MendelsohnNamed on SEC filing

Board

ER
Evan RachlinBoard director
PL
Peter LawrenceBoard director
EM
Edward MathersBoard directorGeneral Partner at NEA Secondary
AKAdam Koppel
Adam KoppelBoard directorManaging Director at Bain Capital Life Sciences
NDNicholas Downing
Nicholas DowningBoard directorPartner at Bain Capital Life Sciences
JKJeb Keiper
Jeb KeiperBoard directorInvestor at Third Rock Ventures
DL
Daniel LynchBoard director
ER
Emma ReeveBoard director

Investors · 6

Bain Capitalreported

How we know: funding news · Not right? Tell us

Bain Capital Tech OpportunitiesreportedBoston

How we know: press coverage · Not right? Tell us

NEA SecondaryinferredTimonium

How we know: board seat on SEC Form D · Not right? Tell us

Polaris PartnersinferredBoston · $500K – $5Mvia Amy Schulman · board

How we know: board seat on SEC Form D · Not right? Tell us

Third Rock VenturesinferredBoston · $100K – $5Mvia Jeb Keiper · board

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$431.7M disclosed across 5 rounds · 2017–2024

▶$260.4MraisedJul 2024 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Evan RachlinDirector
  • Jeb KeiperDirector
  • Michael MendelsohnExecutive Officer, Director
  • Daniel LynchDirector
  • Emma ReeveDirector
  • Peter LawrenceExecutive Officer, Director
  • Edward MathersDirector
  • Adam KoppelDirector
  • Nicholas DowningDirector
Offering amount
$260.4M
Amount sold
$260.4M
First sale
Jul 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$128.1MraisedJul 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam KoppelDirector
  • Keith GottesdienerDirector
  • Kenneth NovackDirector
  • Jeb KeiperDirector
  • Nicholas DowningDirector
  • Michael MendelsohnExecutive Officer, Director
  • Peter LawrenceExecutive Officer, Director
Offering amount
$128.1M
Amount sold
$128.1M
Finders' fees
$3.1M
Placement agents
SVB Leerink LLC
First sale
Oct 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.5MraisedDec 2022 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam KoppelDirector
  • Kenneth NovackDirector
  • Amy SchulmanDirector
  • Peter LawrenceExecutive Officer, Director
  • Nicholas DowningDirector
  • Jeb KeiperDirector
  • Michael MendelsohnExecutive Officer, Director
  • Keith GottesdienerDirector
Offering amount
$17.5M
Amount sold
$17.5M
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedNov 2019 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeb KeiperDirector
  • Amy SchulmanDirector
  • Kenneth NovackDirector
  • Michael MendelsohnExecutive Officer, Director
Offering amount
$10M
Amount sold
$10M
First sale
Nov 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.7MraisedApr 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael MendelsohnExecutive Officer, Director
Offering amount
$22.4M
Amount sold
$15.7M
First sale
Mar 2017
Incorporated
Limited Liability Company, Georgia, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Cardurion Pharmaceuticals, Inc.'s investors?
Cardurion Pharmaceuticals, Inc.'s investors include Bain Capital Life Sciences, Bain Capital, Bain Capital Tech Opportunities, NEA Secondary, Polaris Partners, Third Rock Ventures.
How much funding has Cardurion Pharmaceuticals, Inc. raised?
Cardurion Pharmaceuticals, Inc. has disclosed $431.7M raised across 5 rounds.
Where is Cardurion Pharmaceuticals, Inc. headquartered?
Cardurion Pharmaceuticals, Inc. is headquartered in Burlington, US.